Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Clinically isolated syndrome - Rethinking the diagnosis.
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Episode 39 with Dr. Joseph Berger on diagnostic dilemmas in MS
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
American Academy of Neurology 2012 Annual Meeting
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
ACRM I American Congress of Rehabilitation
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).

Pages